BONINI, Sergio
 Distribuzione geografica
Continente #
NA - Nord America 4.044
EU - Europa 4.041
AS - Asia 529
SA - Sud America 36
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 8.677
Nazione #
US - Stati Uniti d'America 4.033
IE - Irlanda 1.318
UA - Ucraina 981
GB - Regno Unito 620
DE - Germania 374
FI - Finlandia 251
SE - Svezia 191
SG - Singapore 191
GR - Grecia 150
TR - Turchia 148
CN - Cina 99
IT - Italia 91
IN - India 33
BE - Belgio 22
BR - Brasile 21
KR - Corea 16
ID - Indonesia 11
NL - Olanda 9
FR - Francia 8
EU - Europa 7
PK - Pakistan 7
CA - Canada 6
EC - Ecuador 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
ES - Italia 5
JO - Giordania 5
JP - Giappone 5
BD - Bangladesh 4
CO - Colombia 4
MX - Messico 4
AP - ???statistics.table.value.countryCode.AP??? 3
AR - Argentina 3
NZ - Nuova Zelanda 3
RU - Federazione Russa 3
AU - Australia 2
IQ - Iraq 2
IR - Iran 2
LT - Lituania 2
LY - Libia 2
PL - Polonia 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GM - Gambi 1
MA - Marocco 1
MY - Malesia 1
NA - Namibia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SC - Seychelles 1
TW - Taiwan 1
VN - Vietnam 1
Totale 8.677
Città #
Jacksonville 1.463
Dublin 1.317
Chandler 552
Princeton 245
Medford 233
San Mateo 167
Boardman 160
Wilmington 115
Singapore 98
Ann Arbor 89
Woodbridge 66
Roxbury 56
Cambridge 54
Des Moines 36
Ashburn 30
Beijing 20
New York 18
Redwood City 18
Mountain View 17
Nanjing 16
Brussels 15
Düsseldorf 15
Pune 14
Rome 12
Houston 11
Jinan 11
Norwalk 11
Kunming 8
São Paulo 8
Fairfield 7
Los Angeles 7
Auburn Hills 6
London 6
Tianjin 6
Bremen 5
Città di Castello 5
Haikou 5
Nanchang 5
Orange 5
Quito 5
Seattle 5
Shanghai 5
Dhaka 4
Groningen 4
Hebei 4
L'aquila 4
Longueville 4
Malappuram 4
Pakistan 4
Seoul 4
Třebíč 4
Arzano 3
Brantford 3
Duncan 3
Helsinki 3
Lappeenranta 3
Oristano 3
Patras 3
Santa Clara 3
Taiyuan 3
Venice 3
Belgrade 2
Berlin 2
Bogotá 2
Capannelle 2
Caserta 2
Champaign 2
Changsha 2
Flensburg 2
Gangseo-gu 2
Ghent 2
Hangzhou 2
Hanover 2
Jūnāgadh 2
Lahore 2
Lanzhou 2
Madrid 2
Melbourne 2
Milan 2
Missaglia 2
Munro 2
Naples 2
Patna 2
Pavia 2
Saint Ives 2
Shenyang 2
Stony Brook 2
Toronto 2
Vanzaghello 2
Adana 1
Amsterdam 1
Andover 1
Appiano Gentile 1
Avellino 1
Bandung 1
Bangkok 1
Berkeley 1
Bydgoszcz 1
Centrale 1
Cesenatico 1
Totale 5.080
Nome #
Global Allergy and Asthma European Network: Grading of Recommendations Assessment, Development and Evaluation Working Group: Allewrgic Rhinitis and its Impact on Asthma (ARIA) Guidelines: 2010 revision 187
Allergic Rhinitis and its Impact on Asthma (ARIA): In collaboration with the World Health Organization 113
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project 63
POLLENOSIS 2000. GLOBAL APPROACH 63
GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases 60
The genetics of atopy 60
Uso del Fattore di crescita nervoso (NGF)per l'espansione in vitro di cellule staminali del cordone ombelicale 60
Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche 57
GA2LEN (GLOBAL ALLERGY AND ASTHMA EUROPEAN NETWORK) ADDRESSES THE ALLERGY AND ASTHMA 'EPIDEMIC' 56
Epidemiology of allergic occupational diseases induced by Tetranychus urticae in greenhouse and open-field farmers living in a temperate climate area 55
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 54
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update 54
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 54
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) 52
Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation 52
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. 52
Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface 52
GA(2)LEN SKIN TEST STUDY I: GA(2)LEN HARMONIZATION OF SKIN PRICK TESTING: NOVEL SENSITIZATION PATTERNS FOR INHALANT ALLERGENS IN EUROPE 51
Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. 51
Reply 51
Integrated care pathways for airway diseases (AIRWAYS-ICPs). 50
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN 50
Adult SURF Study Group. A survey of clinical features of allergic rhinitis in adults 50
Microbial products in allergy prevention and therapy 49
Nerve Growth Factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing 49
Desloratadina: a new approach in the treatment of allergy as a systemic disease - pharmacology and clinical overview 49
Severe Chronic Allergic (and Related) Diseases: A Uniform Approach - A MeDALL - GA(2)LEN - ARIA Position Paper. 48
Dampness in buildings as a risk factor for health effects, EUROEXPO: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects. 48
Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis 48
The eosinophil and the eye 48
Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas 48
Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis 48
EXERCISE-INDUCED ASTHMA, RESPIRATORY AND ALLERGIC DISORDERS IN ELITE ATHLETES: EPIDEMIOLOGY, MECHANISMS AND DIAGNOSIS: PART I OF THE REPORT FROM THE JOINT TASK FORCE OF THE EUROPEAN RESPIRATORY SOCIETY (ERS) AND THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY (EAACI) IN COOPERATION WITH GA2LEN 47
Primer di Allerghologia e Immunologia Clinica 47
Non specific provocation of target organs in allergic diseases 46
Allergen extracts. Standardization of preparations for bronchial provocation tests. A position paper. (EAACI Sub-committee on Bronchial Provocation Tests) 46
Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. 46
Global Approach to the atopic Patient 46
GA(2)LEN SKIN TEST STUDY II: CLINICAL RELEVANCE OF INHALANT ALLERGEN SENSITIZATIONS IN EUROPE 45
Allergenic pollen and pollen allergy in Europe 45
Reply to the letter of Dr. Feinberg in J Allergy Clin Immunol 1990; 85:141-2 45
WHO Intiative. Allergic Rhinitis and its Impact on Asthma (ARIA) 45
Copyright. AQUE. Allergy Questionnaire for Exercisers 45
Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper 44
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA(2)LEN and InterAirways document 44
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper 44
Topical treatment with nerve growth factor for corneal neurotrophic ulcers 44
International consensus on allergy immunotherapy 44
Allergen immunotherapy on the way to product-based evaluation - a WAO statement 44
Nerve Growth Factor and tissue repair remodeling : trkA (NGFR) and p75 (NTR) two receptors one fate. 43
Practical approach to diagnosis and treatment of ocular allergy: a 1-year systematic review 43
GA2LEN SKIN TEST STUDY III: MINIMUM BATTERY OF TEST INHALENT ALLERGENS NEEDED IN EPIDEMIOLOGICAL STUDIES IN PATIENTS 43
Bridging allergologic and botanical knowledge in seasonal allergy, 42
Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network 42
What we should learn from the London Olympics. 42
Allergy, asthma and markers of infections among Albanian migrants to Southern Italy. 42
Nerve Growth Factor has a modulatory role on human primary fibroblast coltures derived from vernal keratoconjunctivitis-affected conjunctiva 42
[Phadiatop, a new in vitro method in the diagnosis and prevention of respiratory allergic diseases] 42
Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis 42
Copyright. AQUA Allergy Questionnaire for Athletes 42
First-in-human clinical trials - What we can learn from tragic failures 42
Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA 42
The relation between paracetamol use and asthma: a GA2LEN European case-control study 41
Effects of Salmeterol on Skeletal Muscle Cells: Metabolic and Pro-Apoptotic Features. 41
Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One 41
Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis 41
IgE serum levels in urinary schistosomiasis 41
Copyright. QUAQUA. Quality of life Questionnaire for Athletes 41
Markers of eosinophilic inflammation in allergic diseases 40
Desloratadine: a new approach in the treatment of allergy as a systematic disease--pharmacology and clinical overview. Introduction 40
Effects of topical pre-treatment with dexamethasone on the immediate and late phases of topically induced ocular anaphylaxis in the rat 40
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. 40
Clinical trials in allergic conjunctivits: a systematic review. 40
T-helper 17 lymphocytes in ocular cicatricial pemphigoid 40
Allergic bronchial airway inflammation in Nerve Growth Factor (NGF) – derived rats: evidence suggesting a neuroimmunomodulatory role of NGF 40
Why is the incidence of asthma increasing? 40
Weight loss interventions in asthma: EAACI evidence-based clinical practice guideline (part I). 39
Intestinal permeability in patients with adverse reactions to food 39
Immunological profile of peripheral blood eosinophils in acute graft-vs-host disease 39
Protocolli Allergologici e Immunologici per la Gestione degli Atleti Agonisti e Non-Agonisti 39
Increased plasma levels of substance P in vernal keratoconjunctivitis 39
Evidence of non reproducibility. Human basophil histamine release is not triggered by very diluted anti-IgE. Letter 39
An allergist is the new Executive Director of the European Medicine Agency.Editorial. 39
Allergen dose response and late symptoms in a human model of ocular allergy 39
Tear tryptase levels and allergic conjunctivitis 38
CLOSE CORRELATION BETWEEN ANXIETY; DEPRESSION; AND ASTHMA CONTROL, 38
Airway inflammation in the elite athlete and type of sport 38
[New methods in allergology] 38
TLR4 and TLR9 Expression in Different Phenotypes of Rhinitis. 38
Allergic conjunctivitis 37
Epidemiology of rhinitis and conjunctivitis in athletes. 37
Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy) 37
The role of shock organs in influencing the clinical expression of allergy 37
[Autoimmunity and lymphoproliferative diseases (proceedings)] 37
Immunophenotypic profile of peripheral blood eosinophils in acute graft-vs.-host disease 36
Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome 36
Flow cytometric evaluation of activated eosinophils in graft versus host disease and hypereosinophilic conditions 36
IgG subclass antibodies against Parietaria judaica in normal and allergic subjects 36
Immunotherapy of bronchial asthma 36
Manual of Clinical Trials in Allergy and Clinical Immunology 36
Totale 4.667
Categoria #
all - tutte 39.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020724 0 0 5 6 244 15 261 10 139 17 20 7
2020/20211.814 226 0 259 60 269 4 254 245 0 281 181 35
2021/20221.233 173 1 2 14 492 3 20 38 46 4 94 346
2022/20232.186 251 3 8 169 190 179 1 146 1.151 12 43 33
2023/2024912 72 23 31 131 374 37 4 30 13 9 40 148
2024/202533 13 20 0 0 0 0 0 0 0 0 0 0
Totale 8.755